Decitabine for High-Risk Sickle Cell Disease

NCT01375608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Neutropenia
Sickle Cell Disease

Interventions

DRUG: Decitabine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)